Compare Erasca Inc. Common Stock (ERAS) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Erasca Inc. Common Stock vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Erasca Inc. Common Stock trades at $15.57 (market cap $4.95B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.32 (market cap $2.28B). The key difference: Erasca Inc. Common Stock is far larger — about 2.2× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Erasca Inc. Common Stock is more actively traded (3,834,689 versus 3,128,960). Which is the better fit depends on your goals.
| ERAS | SLS | |
|---|---|---|
Market Cap | $4.95B | $2.28B |
Volume | 3,834,689 | 3,128,960 |
Sector | Health | Health |
52-Week High | $22.47 | $15.46 |
52-Week Low | $2.20 | $1.39 |
Typical Hold Time | 0 Days | — |
Enterprise Value | $4.72B | $2.15B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Erasca Inc. Common Stock
Erasca is a biotechnology company developing precision medicines for cancer. Its programs target genetic drivers of tumor growth.
Read more on ERAS →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
